glp 1 agonist crohn's disease Relevance of Glucagon-Like Peptide (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review This study reviews existing research
Description
Approximately 2242% of patients with CAD also suffer from PAD
DPP-4 inhibitors are one of the few oral agents that are useful in patients with significant renal impairment
107,203 The physiological relevance of GLP-1 metabolites remains an area of controversy
This activity of GLP-1 has been demonstrated in both preclinical and clinical studies, and the results support the hypothesis that the GLP-1 pathway regulates the processes of alcohol use disorder (AUD)
Crit Rev Oncol Hematol
doi:10.3389/fneur.2022.844697 Edison P, et al
